Cipla
Cipla Limited, a leading global pharmaceutical company headquartered in India, has been a pioneer in the healthcare industry since its establishment in 1935. With a strong presence in over 80 countries, Cipla focuses on developing a wide range of generic medicines, active pharmaceutical ingredients (APIs), and over-the-counter products. Renowned for its commitment to affordable healthcare, Cipla has made significant strides in areas such as respiratory, cardiovascular, and anti-retroviral therapies. The company is distinguished by its innovative approach to drug development and its robust pipeline of products, which cater to diverse therapeutic needs. Cipla's market position is bolstered by its extensive distribution network and strategic partnerships, making it a trusted name in the pharmaceutical sector. With numerous accolades for its contributions to global health, Cipla continues to lead the way in providing high-quality, accessible medicines.
DitchCarbon Score
How does Cipla's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cipla's score of 61 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cipla's reported carbon emissions
In 2024, Cipla reported total carbon emissions of approximately 4,577,672,000 kg CO2e, with significant contributions from Scope 3 emissions, which accounted for about 4,576,772,000 kg CO2e. Scope 1 emissions were reported at approximately 37,398,000 kg CO2e, while Scope 2 emissions totalled around 207,238,000 kg CO2e. Cipla has set ambitious climate commitments, aiming for carbon neutrality in its Scope 1 and Scope 2 emissions for its India manufacturing operations by December 2025. This goal aligns with their broader strategy to enhance energy efficiency and increase the use of renewable energy sources. Additionally, they plan to reduce Scope 2 emissions by 30% from 2020 levels by 2030 and aim to achieve near-zero Scope 1 and Scope 2 emissions by 2025. In 2023, Cipla's Scope 2 emissions were reported at approximately 153,882,000 kg CO2e, indicating a focus on reducing these figures in line with their long-term sustainability goals. The company is actively working towards these targets, reflecting a commitment to addressing climate change and reducing its overall carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 236,358,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 55,013,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | 00,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cipla is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
